Guidelines of care for the management of atopic dermatitis: Section 3. Management and treatment with phototherapy and systemic agents

Robert Sidbury, Dawn M. Davis, David E. Cohen, Kelly M. Cordoro, Timothy G. Berger, James N. Bergman, Sarah L. Chamlin, Kevin D. Cooper, Steven R. Feldman, Jon M. Hanifin, Alfons Krol, David J. Margolis, Amy S. Paller, Kathryn Schwarzenberger, Robert A. Silverman, Eric L. Simpson, Wynnis L. Tom, Hywel C. Williams, Craig A. Elmets, Julie BlockChristopher G. Harrod, Wendy Smith Begolka, Lawrence F. Eichenfield

Research output: Contribution to journalArticlepeer-review

661 Scopus citations

Abstract

Atopic dermatitis is a chronic, pruritic inflammatory dermatosis that affects up to 25% of children and 2% to 3% of adults. This guideline addresses important clinical questions that arise in atopic dermatitis management and care, providing recommendations based on the available evidence. In this third of 4 sections, treatment of atopic dermatitis with phototherapy and systemic immunomodulators, antimicrobials, and antihistamines is reviewed, including indications for use and the risk-benefit profile of each treatment option.

Original languageEnglish (US)
Pages (from-to)327-349
Number of pages23
JournalJournal of the American Academy of Dermatology
Volume71
Issue number2
DOIs
StatePublished - Aug 2014

Keywords

  • atopic dermatitis
  • azathioprine
  • cyclosporin A
  • interferon gamma
  • methotrexate
  • mycophenolate mofetil
  • oral antihistamines
  • oral antimicrobials
  • oral steroids
  • photochemotherapy
  • phototherapy
  • systemic therapy

ASJC Scopus subject areas

  • Dermatology

Fingerprint

Dive into the research topics of 'Guidelines of care for the management of atopic dermatitis: Section 3. Management and treatment with phototherapy and systemic agents'. Together they form a unique fingerprint.

Cite this